The Shield blood test is often mentioned as an alternative way to screen for colon cancer because it has been approved for certain circumstances.  I.e. it allows primary doctors to comply with certain government guidelines.

However the test is extremely insensitive for colon polyps!

In the pivotal Eclipse trial published in the New England Journal of Medicine ( vol 390. No 11) in March 2024, 83% of patients with colon cancer had a positive test. However the sensitivity for advanced precancerous lesions i.e. polyps that can be over 1 cm in size, was only 13.2%!

Our goal when we perform a colonoscopy is to remove polyps at the earliest stages.The Shield test is poor at detecting small and medium sized precancerous polyps, when it is easier and safer to remove them.  It has little value for someone who has had a prior colonoscopy and is due for routine follow-up. 

Marketing vs. Medical Reality

 Advertisements may suggest that the Shield test can replace colonoscopy, but this simply isn’t accurate. it’s marketed as an alternative for those who would otherwise avoid all screening.

When Might Shield Test Be Appropriate?

The Shield test does have a place in colon cancer screening, but it’s limited. It may be appropriate for patients who absolutely refuse colonoscopy despite counseling about the benefits, have medical conditions that make colonoscopy too risky, or live in areas where access to colonoscopy is severely limited.

Even in these cases, patients must understand that they’re accepting significantly reduced detection rates and may still need colonoscopy if the test is positive.

My Professional Recommendation

Colonoscopy remains the gold standard because it:


Dr. Michael Braunstein is a board-certified gastroenterologist with over 25 years of experience in private practice. He personally performs every procedure and sees every patient, ensuring continuity of care and personalized attention

Leave a Reply

Your email address will not be published. Required fields are marked *